Chronic obstructive pulmonary disease.

Area of Science:

• Pulmonary Medicine
• Respiratory Physiology
• Pathobiology

Background:

• COPD is defined by airflow limitation not fully reversible, stemming from obstructive airway disease and alveolar destruction.
• Structural changes in COPD include airway obstruction and reduced lung vascularity, particularly in emphysema.
• Physiological changes manifest as airflow obstruction, often detected by spirometry (reduced FEV1/FVC ratio).

Purpose of the Study:

• To provide insight into the histological, functional, and biological features of COPD.
• To clarify pathobiological processes underlying COPD.
• To highlight evolving therapeutic options for COPD management.

Main Methods:

• Spirometry to assess airflow obstruction (FEV1/FVC ratio).
• Evaluation of bronchoreversibility to aid COPD diagnosis.
• Analysis of lung mechanics, including lung hyperinflation (FRC) and its link to expiratory flow limitation.

Main Results:

• Spirometry confirms airflow obstruction, though early stages may not show reduced FEV1 or airway conductance.
• Lung hyperinflation (increased FRC) is a key functional consequence, impacting inspiratory muscle load.
• Reduced exercise tolerance is linked to breathlessness and altered lung mechanics.

Conclusions:

• Decades of research have elucidated COPD's features, improving understanding of its pathobiology.
• Lung function measurements, like FEV1, serve as prognostic indices and disease progression monitors.
• Enhanced understanding has led to additional therapeutic strategies for COPD.